Levamisol Arena

Levamisole, the active ingredient in Levamisol Arena, is an anthelmintic presented as a tablet for oral use. It treats intestinal helminth infections such as ascariasis and hookworm in patients requiring deworming.

GNH USA supplies Levamisol Arena as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levamisole is used to treat parasitic worm infections affecting the gastrointestinal tract.

- Ascariasis: eliminates Ascaris lumbricoides worms and reduces associated gastrointestinal symptoms. - Hookworm infection: eradicates Ancylostoma duodenale and Necator americanus and alleviates anemia. - Trichuriasis: removes Trichuris trichiura and improves bowel function.

Levamisole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient stomach upset after dosing. - Vomiting: occasional emesis, usually self‑limiting. - Abdominal pain: mild cramping or discomfort. - Dizziness: transient light‑headedness. - Skin rash: mild erythema or pruritus. - Mild leukopenia: slight reduction in white‑blood‑cell count.

Serious or Rare Side Effects: - Agranulocytosis: severe drop in neutrophils, requiring immediate medical attention. - Stevens‑Johnson syndrome: rare severe skin reaction with blistering. - Hepatotoxicity: elevated liver enzymes indicating liver injury. - Severe neutropenia: marked decrease in neutrophils, increasing infection risk. - Anaphylaxis: rare systemic allergic reaction.

Before prescribing Levamisol Arena, clinicians should consider several safety aspects.

- Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown excretion; consider alternative therapy. - Renal impairment: use with caution and monitor renal function. - Hematologic monitoring: obtain baseline complete blood count and repeat as needed. - Concomitant immunosuppressants: assess infection risk before co‑administration. - Store at room temperature: keep in the original container, protect from moisture and light.

Levamisole can interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Immunosuppressants: may increase risk of severe infection. - Cytotoxic chemotherapy: additive bone‑marrow suppression. - Live vaccines: reduced efficacy and possible infection.

Moderate Interactions (Monitor Closely): - Anticoagulants: potential enhancement of bleeding. - CYP450 inhibitors/inducers: may alter levamisole plasma levels. - Other anthelmintics: possible additive toxicity, monitor for adverse signs.